Knowledge Center
Article / Jun 01, 2009
Substandard APIs: we must tackle the problem together
Source:
Pharmaceutical Technology Europe, June, 2009
Contrary to what some would have you believe, the use of substandard APIs in European medicines puts patient health and pharmaceutical manufacturers' reputations at risk. Most APIs destined for the EU come from Asian plants that have never been inspected by an EU official. To ensure a minimum level of quality, agencies and regulators from both sides of the Atlantic must work together to provide API compliance oversight.
Related links
Also in the Knowledge Center
/ Oct 19, 2026
A dimensionless framework for hold-up mass prediction and scale transfer in continuous linear blending
Read more
Scientific Article
/ Oct 26, 2026
Streamlined development of continuous blending through integrated process understanding and predictive modeling
Read more
Scientific Article
/ Aug 04, 2026
Hovione: Accelerating Oral Drug Development Through Rapid Prototyping and Integrated Development Strategies
Read more
Scientific Article